Skip to content
OpenCapital
Get started

TherapeuticsMD TXMD Q1 2025 Annual earnings

Reported May 13, 2025 · Before market open

Revenue$393.0KDiluted EPS-$0.06

Next report

Aug 17, 2026 (in a month)
Revenue estimate$22.1M
EPS estimate-$5.50

Versus estimates

Revenue

Q1 2026$724.0KMiss by $19.0MQ4 2025$893.0KMiss by $18.9MQ3 2025$784.0KQ2 2025$952.0K
Q1 2025$393.0K
Q4 2024$667.0KMiss by $1.6M

Diluted EPS

Q1 2026$0.01Beat by $6.14Q4 2025-$0.05Beat by $6.07Q3 2025$0.01Q2 2025$0.05
Q1 2025-$0.06
Q4 2024$0.02Miss by $0.02

Ask the moment TherapeuticsMD reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did TherapeuticsMD report Q1 2025 earnings?
TherapeuticsMD (TXMD) reported Q1 2025 earnings on May 13, 2025 before market open.
What were TherapeuticsMD's Q1 2025 revenue and EPS?
TherapeuticsMD reported revenue of $393.0K and diluted EPS of $-0.06 for Q1 2025.
How did TherapeuticsMD's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 25.6% from $313.0K a year earlier and diluted EPS grew 14.3% from $-0.07.
Where can I find TherapeuticsMD's Q1 2025 SEC filings?
You can read the 10-K/A periodic report (0001213900-25-037713) directly on SEC EDGAR. The filing index links above go to sec.gov.